Subscribe via RSS Feed Connect on Pinterest Connect on Google Plus Connect on YouTube

NIH clinical trial of investigational vaccine for COVID-19 begins

Filed in COVID-19 Science, Local Health News, Newsroom 3/20/20 at 2:32 pm     177     National Institute of Health

A Phase 1 clinical trial evaluating an investigational vaccine designed to protect against coronavirus disease 2019 (COVID-19) has begun at Kaiser Permanente Washington Health Research Institute (KPWHRI) in Seattle. The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is funding the trial. KPWHRI is part of NIAID’s Infectious Diseases Clinical Research Consortium. The open-label trial will enroll 45 healthy adult volunteers ages 18 to 55 years over approximately 6 weeks. The first participant received the investigational vaccine on Monday, March 16.

Read the rest at National Institute of Health